Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Jan;36(1):191–194. doi: 10.1128/aac.36.1.191

Effects of multiple doses of isoprinosine on Echinococcus multilocularis metacestodes.

M E Sarciron 1, I Delabre 1, S Walbaum 1, G Raynaud 1, A F Petavy 1
PMCID: PMC189252  PMID: 1375448

Abstract

Isoprinosine was given at daily doses of 0.5, 1, 2, and 4 g kg-1 of body weight to jirds that were infected for 3 months with Echinococcus multilocularis metacestodes. The effects of the different drug doses on metacestodes were studied by transmission electron microscopy and biochemical methods. At lower doses, increases in uric acid and adenosine deaminase activity were noted. At 4 g kg-1 of body weight, marked ultrastructural damage with metabolic perturbations was observed.

Full text

PDF
191

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bensadoun A., Weinstein D. Assay of proteins in the presence of interfering materials. Anal Biochem. 1976 Jan;70(1):241–250. doi: 10.1016/s0003-2697(76)80064-4. [DOI] [PubMed] [Google Scholar]
  2. Blake J., Berman P. The use of adenosine deaminase assays in the diagnosis of tuberculosis. S Afr Med J. 1982 Jul 3;62(1):19–21. [PubMed] [Google Scholar]
  3. Davis A., Dixon H., Pawlowski Z. S. Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2). Bull World Health Organ. 1989;67(5):503–508. [PMC free article] [PubMed] [Google Scholar]
  4. Davis A., Pawlowski Z. S., Dixon H. Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Bull World Health Organ. 1986;64(3):383–388. [PMC free article] [PubMed] [Google Scholar]
  5. Delabre-Defayolle I., Sarciron M. E., Audin P., Gabrion C., Duriez T., Paris J., Petavy A. F. Echinococcus multilocularis metacestodes: biochemical and ultrastructural investigations on the effect of isatin (2-3 indoline dione) in vivo. J Antimicrob Chemother. 1989 Feb;23(2):237–245. doi: 10.1093/jac/23.2.237. [DOI] [PubMed] [Google Scholar]
  6. Horton R. J. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg. 1989 Jan-Feb;83(1):97–102. doi: 10.1016/0035-9203(89)90724-4. [DOI] [PubMed] [Google Scholar]
  7. Keystone J. S., Murdoch J. K. Mebendazole. Ann Intern Med. 1979 Oct;91(4):582–586. doi: 10.7326/0003-4819-91-4-582. [DOI] [PubMed] [Google Scholar]
  8. Morris D. L., Richards K. S., Clarkson M. J., Taylor D. H. Comparison of Albendazole and Praziquantel therapy of Echinococcus granulosus in naturally infected sheep. Vet Parasitol. 1990 May;36(1-2):83–90. doi: 10.1016/0304-4017(90)90096-t. [DOI] [PubMed] [Google Scholar]
  9. Morris D. L., Taylor D. H. Optimal timing of post-operative albendazole prophylaxis in E. granulosus. Ann Trop Med Parasitol. 1988 Feb;82(1):65–66. doi: 10.1080/00034983.1988.11812210. [DOI] [PubMed] [Google Scholar]
  10. Senft A. W., Crabtree G. W. Purine metabolism in the schistosomes: potential targets for chemotherapy. Pharmacol Ther. 1983;20(3):341–356. doi: 10.1016/0163-7258(83)90031-1. [DOI] [PubMed] [Google Scholar]
  11. Steiger U., Cotting J., Reichen J. Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance. Clin Pharmacol Ther. 1990 Mar;47(3):347–353. doi: 10.1038/clpt.1990.38. [DOI] [PubMed] [Google Scholar]
  12. Taylor D. H., Richards K. S., Morris D. L. Rapid recovery of Echinococcus granulosus following 'successful' albendazole therapy in a gerbil model. J Helminthol. 1989 Dec;63(4):349–352. doi: 10.1017/s0022149x00009251. [DOI] [PubMed] [Google Scholar]
  13. Van den Bossche H., Rochette F., Hörig C. Mebendazole and related anthelmintics. Adv Pharmacol Chemother. 1982;19:67–128. doi: 10.1016/s1054-3589(08)60021-6. [DOI] [PubMed] [Google Scholar]
  14. Vanparijs O. Chemotherapy of experimental Echinococcus multilocularis in jirds. Parasitol Res. 1990;76(3):238–240. doi: 10.1007/BF00930820. [DOI] [PubMed] [Google Scholar]
  15. Wilson J. F., Rausch R. L., McMahon B. J., Schantz P. M., Trujillo D. E., O'Gorman M. A. Albendazole therapy in alveolar hydatid disease: a report of favorable results in two patients after short-term therapy. Am J Trop Med Hyg. 1987 Jul;37(1):162–168. doi: 10.4269/ajtmh.1987.37.162. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES